S&P 500   4,291.58 (-0.13%)
DOW   33,961.07 (+0.14%)
QQQ   331.49 (-0.47%)
AAPL   172.61 (-0.33%)
MSFT   292.63 (-0.29%)
META   178.63 (-1.25%)
GOOGL   121.82 (-0.21%)
AMZN   143.41 (+0.16%)
TSLA   939.16 (+1.21%)
NVDA   188.12 (-1.16%)
NIO   20.96 (-1.60%)
BABA   91.98 (-2.36%)
AMD   100.25 (-0.75%)
MU   63.67 (-1.59%)
T   18.40 (+0.05%)
CGC   3.67 (-3.93%)
F   16.35 (+0.18%)
GE   79.20 (-0.76%)
DIS   124.05 (-0.17%)
AMC   24.34 (+0.54%)
PYPL   100.94 (-0.56%)
PFE   49.68 (-0.14%)
NFLX   247.12 (-0.80%)
S&P 500   4,291.58 (-0.13%)
DOW   33,961.07 (+0.14%)
QQQ   331.49 (-0.47%)
AAPL   172.61 (-0.33%)
MSFT   292.63 (-0.29%)
META   178.63 (-1.25%)
GOOGL   121.82 (-0.21%)
AMZN   143.41 (+0.16%)
TSLA   939.16 (+1.21%)
NVDA   188.12 (-1.16%)
NIO   20.96 (-1.60%)
BABA   91.98 (-2.36%)
AMD   100.25 (-0.75%)
MU   63.67 (-1.59%)
T   18.40 (+0.05%)
CGC   3.67 (-3.93%)
F   16.35 (+0.18%)
GE   79.20 (-0.76%)
DIS   124.05 (-0.17%)
AMC   24.34 (+0.54%)
PYPL   100.94 (-0.56%)
PFE   49.68 (-0.14%)
NFLX   247.12 (-0.80%)
S&P 500   4,291.58 (-0.13%)
DOW   33,961.07 (+0.14%)
QQQ   331.49 (-0.47%)
AAPL   172.61 (-0.33%)
MSFT   292.63 (-0.29%)
META   178.63 (-1.25%)
GOOGL   121.82 (-0.21%)
AMZN   143.41 (+0.16%)
TSLA   939.16 (+1.21%)
NVDA   188.12 (-1.16%)
NIO   20.96 (-1.60%)
BABA   91.98 (-2.36%)
AMD   100.25 (-0.75%)
MU   63.67 (-1.59%)
T   18.40 (+0.05%)
CGC   3.67 (-3.93%)
F   16.35 (+0.18%)
GE   79.20 (-0.76%)
DIS   124.05 (-0.17%)
AMC   24.34 (+0.54%)
PYPL   100.94 (-0.56%)
PFE   49.68 (-0.14%)
NFLX   247.12 (-0.80%)
S&P 500   4,291.58 (-0.13%)
DOW   33,961.07 (+0.14%)
QQQ   331.49 (-0.47%)
AAPL   172.61 (-0.33%)
MSFT   292.63 (-0.29%)
META   178.63 (-1.25%)
GOOGL   121.82 (-0.21%)
AMZN   143.41 (+0.16%)
TSLA   939.16 (+1.21%)
NVDA   188.12 (-1.16%)
NIO   20.96 (-1.60%)
BABA   91.98 (-2.36%)
AMD   100.25 (-0.75%)
MU   63.67 (-1.59%)
T   18.40 (+0.05%)
CGC   3.67 (-3.93%)
F   16.35 (+0.18%)
GE   79.20 (-0.76%)
DIS   124.05 (-0.17%)
AMC   24.34 (+0.54%)
PYPL   100.94 (-0.56%)
PFE   49.68 (-0.14%)
NFLX   247.12 (-0.80%)
NYSE:DVA

DaVita - DVA Stock Forecast, Price & News

$92.34
-0.14 (-0.15%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$91.09
▼
$93.12
50-Day Range
$76.05
▼
$95.33
52-Week Range
$74.97
▼
$133.88
Volume
498,577 shs
Average Volume
862,341 shs
Market Capitalization
$8.43 billion
P/E Ratio
11.46
Dividend Yield
N/A
Price Target
$104.43

DaVita MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
13.1% Upside
$104.43 Price Target
Short Interest
Healthy
4.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
-0.09mentions of DaVita in the last 14 days
Based on 16 Articles This Week
Insider Trading
Acquiring Shares
$1.55 M Bought Last Quarter
Proj. Earnings Growth
28.52%
From $7.68 to $9.87 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

Medical Sector

163rd out of 1,124 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

4th out of 12 stocks

See Top Rated MarketRank™ Stocks Here
DVA stock logo

About DaVita (NYSE:DVA) Stock

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Stock Performance

DVA traded down $0.14 on Monday, reaching $92.34. 498,577 shares of the stock were exchanged, compared to its average volume of 816,662. The company's 50-day moving average price is $85.89 and its 200 day moving average price is $101.45. DaVita has a fifty-two week low of $74.97 and a fifty-two week high of $133.88. The company has a debt-to-equity ratio of 11.69, a current ratio of 1.41 and a quick ratio of 1.37. The firm has a market capitalization of $8.43 billion, a PE ratio of 11.41, a PEG ratio of 1.43 and a beta of 1.17.

DaVita (NYSE:DVA - Get Rating) last issued its quarterly earnings results on Monday, August 1st. The company reported $2.30 EPS for the quarter, topping analysts' consensus estimates of $2.09 by $0.21. DaVita had a return on equity of 84.69% and a net margin of 7.17%. The company had revenue of $2.93 billion during the quarter, compared to analysts' expectations of $2.93 billion. During the same quarter in the previous year, the firm posted $2.64 EPS. The firm's revenue was up .4% compared to the same quarter last year. As a group, sell-side analysts forecast that DaVita will post 7.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. StockNews.com downgraded DaVita from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 5th. Cowen cut their price target on DaVita to $95.00 in a report on Tuesday, August 9th. Barclays dropped their target price on DaVita from $128.00 to $103.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 4th. Truist Financial dropped their target price on DaVita from $110.00 to $90.00 and set a "hold" rating on the stock in a research note on Wednesday, June 22nd. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on DaVita from $150.00 to $97.00 and set a "buy" rating on the stock in a research note on Tuesday, August 2nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, DaVita presently has an average rating of "Hold" and an average target price of $104.43.

Insiders Place Their Bets

In other DaVita news, Director Barbara J. Desoer sold 2,320 shares of DaVita stock in a transaction dated Friday, June 3rd. The stock was sold at an average price of $97.42, for a total transaction of $226,014.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other DaVita news, Director Barbara J. Desoer sold 2,320 shares of DaVita stock in a transaction dated Friday, June 3rd. The stock was sold at an average price of $97.42, for a total transaction of $226,014.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Michael David Staffieri acquired 20,000 shares of the firm's stock in a transaction dated Thursday, June 23rd. The stock was bought at an average cost of $77.70 per share, with a total value of $1,554,000.00. Following the acquisition, the chief operating officer now owns 61,190 shares in the company, valued at $4,754,463. The disclosure for this purchase can be found here. 1.00% of the stock is currently owned by insiders.

Receive DVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DaVita and its competitors with MarketBeat's FREE daily newsletter.

DVA Stock News Headlines

August 15, 2022 | businesswire.com
Rockwell Medical Announces Second Quarter 2022 Results - Business Wire
August 11, 2022 | americanbankingnews.com
Cowen Lowers DaVita (NYSE:DVA) Price Target to $95.00
August 10, 2022 | washingtonpost.com
Analysis | Dialysis Spending Is Out of Control. Here's How to Rein It In. - The Washington Post
August 10, 2022 | bizjournals.com
DaVita doubles down on large downtown Denver space and hybrid work - The Business Journals
August 9, 2022 | reuters.com
Criminal antitrust labor case survives health managers' bid to dismiss - Reuters.com
August 8, 2022 | fool.com
Down 26%, Is This Buffett Stock a Buy? - The Motley Fool
August 6, 2022 | finance.yahoo.com
A DaVita Inc. (NYSE:DVA) insider increased their holdings by 28% last year
August 6, 2022 | americanbankingnews.com
Barclays Lowers DaVita (NYSE:DVA) Price Target to $103.00
August 4, 2022 | americanbankingnews.com
DaVita (NYSE:DVA) Price Target Cut to $97.00
August 3, 2022 | finance.yahoo.com
Enzo Biochem Appoints Matthew Kupferberg as General Counsel - Yahoo Finance
August 3, 2022 | streetinsider.com
Enzo Biochem Appoints Matthew Kupferberg as General Counsel - StreetInsider.com
August 2, 2022 | finance.yahoo.com
DaVita (DVA) Beats on Q2 Earnings, Reiterates FY22 EPS View
August 2, 2022 | fool.com
DaVita (DVA) Q2 2022 Earnings Call Transcript - The Motley Fool
August 2, 2022 | finance.yahoo.com
DaVita (DVA) Q2 2022 Earnings Call Transcript
August 1, 2022 | in.investing.com
DaVita Tops Q2 EPS by 21c By Investing.com - Investing.com India
August 1, 2022 | finance.yahoo.com
DaVita HealthCare (DVA) Tops Q2 Earnings Estimates - Yahoo Finance
August 1, 2022 | finance.yahoo.com
DaVita HealthCare (DVA) Tops Q2 Earnings Estimates
August 1, 2022 | uk.investing.com
DaVita Tops Q2 EPS by 21c By Investing.com - Investing.com UK
August 1, 2022 | benzinga.com
Recap: DaVita Q2 Earnings - Benzinga
August 1, 2022 | nasdaq.com
DaVita Inc. (NYSE:DVA) insiders who sold US$5.4m worth of stock earlier this year are probably glad they did so as market cap slides to US$8.1b - Nasdaq
August 1, 2022 | finance.yahoo.com
DaVita Inc. 2nd Quarter 2022 Results
July 31, 2022 | barrons.com
AMD, PayPal, Starbucks, Uber, Paramount, and Other Stocks to Watch This Week - Barron's
July 31, 2022 | seekingalpha.com
DaVita HealthCare Partners Q2 2022 Earnings Preview (NYSE:DVA) - Seeking Alpha
July 31, 2022 | americanbankingnews.com
DaVita Inc. (NYSE:DVA) Receives $122.00 Average PT from Brokerages
July 30, 2022 | americanbankingnews.com
DaVita (DVA) Scheduled to Post Earnings on Monday
See More Headlines
Receive DVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DaVita and its competitors with MarketBeat's FREE daily newsletter.

DVA Company Calendar

Last Earnings
8/01/2022
Today
8/16/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Health Care Services
Sector
Medical
Current Symbol
NYSE:DVA
CUSIP
23918K10
CIK
927066
Web
www.davita.com
Phone
(720) 631-2100
Fax
302-636-5454
Employees
69,000
Year Founded
1999

Price Target and Rating

Average Stock Price Forecast
$104.43
High Stock Price Forecast
$145.00
Low Stock Price Forecast
$90.00
Forecasted Upside/Downside
+13.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$8.06
Trailing P/E Ratio
11.46
Forward P/E Ratio
12.02
P/E Growth
1.43
Net Income
$978.45 million
Net Margins
7.17%
Pretax Margin
11.36%
Return on Equity
84.69%
Return on Assets
4.98%

Debt

Debt-to-Equity Ratio
11.69
Current Ratio
1.41
Quick Ratio
1.37

Sales & Book Value

Annual Sales
$11.62 billion
Price / Sales
0.73
Cash Flow
$16.49 per share
Price / Cash Flow
5.60
Book Value
$9.19 per share
Price / Book
10.05

Miscellaneous

Outstanding Shares
91,300,000
Free Float
90,387,000
Market Cap
$8.43 billion
Optionable
Optionable
Beta
1.17

Social Links


Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













DVA Stock - Frequently Asked Questions

Should I buy or sell DaVita stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DaVita in the last year. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" DVA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DVA, but not buy additional shares or sell existing shares.
View DVA analyst ratings or view top-rated stocks.

What is DaVita's stock price forecast for 2022?

6 Wall Street analysts have issued 1-year price targets for DaVita's shares. Their DVA share price forecasts range from $90.00 to $145.00. On average, they expect the company's share price to reach $104.43 in the next twelve months. This suggests a possible upside of 13.1% from the stock's current price.
View analysts price targets for DVA or view top-rated stocks among Wall Street analysts.

How have DVA shares performed in 2022?

DaVita's stock was trading at $113.76 at the start of the year. Since then, DVA stock has decreased by 18.8% and is now trading at $92.34.
View the best growth stocks for 2022 here.

Are investors shorting DaVita?

DaVita saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 4,660,000 shares, a drop of 6.6% from the July 15th total of 4,990,000 shares. Based on an average daily trading volume, of 1,040,000 shares, the days-to-cover ratio is presently 4.5 days. Currently, 5.0% of the shares of the company are sold short.
View DaVita's Short Interest.

When is DaVita's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our DVA earnings forecast.

How were DaVita's earnings last quarter?

DaVita Inc. (NYSE:DVA) released its quarterly earnings results on Monday, August, 1st. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.09 by $0.21. The company earned $2.93 billion during the quarter, compared to the consensus estimate of $2.93 billion. DaVita had a trailing twelve-month return on equity of 84.69% and a net margin of 7.17%. The company's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.64 earnings per share.
Read the conference call transcript.

What guidance has DaVita issued on next quarter's earnings?

DaVita issued an update on its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share guidance of $7.50-$8.50 for the period, compared to the consensus earnings per share estimate of $7.87. The company issued revenue guidance of -.

What is Javier Rodriguez's approval rating as DaVita's CEO?

289 employees have rated DaVita Chief Executive Officer Javier Rodriguez on Glassdoor.com. Javier Rodriguez has an approval rating of 77% among the company's employees.

What other stocks do shareholders of DaVita own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DaVita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), AT&T (T), AbbVie (ABBV), Intel (INTC) and AutoZone (AZO).

What is DaVita's stock symbol?

DaVita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Who are DaVita's major shareholders?

DaVita's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State Street Corp (3.03%), Northern Trust Corp (0.76%), Lazard Asset Management LLC (0.75%), Nordea Investment Management AB (0.55%), Todd Asset Management LLC (0.51%) and FMR LLC (0.49%). Insiders that own company stock include Barbara J Desoer, Barbara J Desoer, Charles Berg, Javier Rodriguez, Joel Ackerman, John M Nehra, Kathleen Alyce Waters, Kent J Thiry, Leanne M Zumwalt, Mark N Tompkins, Michael David Staffieri, Pamela M Arway, Pamela M Arway, Paul J Diaz, Paula A Price, Phyllis R Yale and R Ted Weschler.
View institutional ownership trends.

How do I buy shares of DaVita?

Shares of DVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DaVita's stock price today?

One share of DVA stock can currently be purchased for approximately $92.34.

How much money does DaVita make?

DaVita (NYSE:DVA) has a market capitalization of $8.43 billion and generates $11.62 billion in revenue each year. The company earns $978.45 million in net income (profit) each year or $8.06 on an earnings per share basis.

How many employees does DaVita have?

The company employs 69,000 workers across the globe.

Does DaVita have any subsidiaries?
The following companies are subsidiares of DaVita: Aberdeen Dialysis LLC, Accountable Kidney Care LLC, Adair Dialysis LLC, American Fork Dialysis LLC, American Medical Insurance Inc., Animas Dialysis LLC, Arcadia Gardens Dialysis LLC, Ashdow Dialysis LLC, Atlantic Dialysis LLC, Austin Dialysis Centers L.P., Barnell Dialysis LLC, Barrons Dialysis LLC, Barton Dialysis LLC, Bastrop Dialysis LLC, Beachside Dialysis LLC, Beck Dialysis LLC, Bellevue Dialysis LLC, Bemity Dialysis LLC, Beverly Hills Dialysis Partnership, Birch Dialysis LLC, Bladon Dialysis LLC, Bliss Dialysis LLC, Bohama Dialysis LLC, Bowan Dialysis LLC, Braddock Dialysis LLC, Bridges Dialysis LLC, Brimfield Dialysis LLC, Brook Dialysis LLC, Brownsville Kidney Center Ltd., Brownwood Dialysis LLC, Bruno Dialysis LLC, Buckhorn Dialysis LLC, Buford Dialysis LLC, Bullards Dialysis LLC, Bullock Dialysis LLC, Calante Dialysis LLC, Campton Dialysis LLC, Canyon Springs Dialysis LLC, Capes Dialysis LLC, Capital Dialysis Partnership, Capron Dialysis LLC, Carlton Dialysis LLC, Carroll County Dialysis Facility Inc., Carroll County Dialysis Facility Limited Partnership, Cascades Dialysis LLC, Caverns Dialysis LLC, Cedar Dialysis LLC, Centennial LV LLC, Central Carolina Dialysis Centers LLC, Central Georgia Dialysis LLC, Central Iowa Dialysis Partners LLC, Central Kentucky Dialysis Centers LLC, Channel Dialysis LLC, Cheraw Dialysis LLC, Chicago Heights Dialysis LLC, Chipeta Dialysis LLC, Churchill Dialysis LLC, Cinco Rios Dialysis LLC, Clark Dialysis LLC, Clayton Dialysis LLC, Cleburne Dialysis LLC, Clinica Central do Bonfim S.A., Clinton Township Dialysis LLC, Clyfee Dialysis LLC, Columbus-RNA-DaVita LLC, Conconully Dialysis LLC, Continental Dialysis Center Inc., Couer Dialysis LLC, Court Dialysis LLC, Cowell Dialysis LLC, Cowesett Dialysis LLC, Crossings Dialysis LLC, Crystals Dialysis LLC, Cuivre Dialysis LLC, Culbert Dialysis LLC, DC Healthcare International Inc., DNP Management Company LLC, DPS CKD LLC, DV Care Netherlands B.V., DV Care Netherlands C.V., DVA Healthcare - Southwest Ohio LLC, DVA Healthcare Renal Care Inc., DVA Healthcare of Maryland LLC, DVA Healthcare of Massachusetts Inc., DVA Healthcare of New London LLC, DVA Healthcare of Norwich LLC, DVA Healthcare of Pennsylvania LLC, DVA Healthcare of Tuscaloosa LLC, DVA Holdings Pte. Ltd., DVA Laboratory Services Inc., DVA Renal Healthcare Inc., DVA of New York Inc., DaVita - Riverside II LLC, DaVita - Riverside LLC, DaVita - West LLC, DaVita APAC Holding B.V., DaVita Brasil Participações e Serviços de Nefrologia Ltda., DaVita Care (Saudi Arabia), DaVita Dakota Dialysis Center LLC, DaVita Deutschland AG, DaVita Deutschland Beteiligungs GmbH & Co. KG, DaVita El Paso East L.P., DaVita Germany GmbH, DaVita HK Holdings Limited, DaVita HealthCare Brasil Serviços Médicos Ltda., DaVita International Limited, DaVita Nefromed Serviços de Nefrologia Ltda., DaVita Nephron Care Serviços de Nefrologia Ltda., DaVita Rien Serviços de Nefrologia Ltda., DaVita S.A.S., DaVita Serviços de Nefrologia Asa Sul Ltda., DaVita Serviços de Nefrologia Distrito Federal Ltda., DaVita Serviços de Nefrologia Guarulhos Ltda., DaVita Serviços de Nefrologia Jardim das Imbuias Ltda., DaVita Serviços de Nefrologia Taubaté Ltda., DaVita Serviços de Nefrologia de Araraquara Ltda., DaVita Sp. z o.o., DaVita Sud-Niedersachsen GmbH, DaVita Transrim Serviços de Nefrologia Ltda., DaVita UTR Serviços de Nefrologia Ltda., DaVita VillageHealth Inc., DaVita of New York Inc., Dallas-Fort Worth Nephrology L.P., Damon Dialysis LLC, Dialysis Holdings Inc., Dialysis of Des Moines LLC, Dialysis of Northern Illinois LLC, Dierks Dialysis LLC, Dolores Dialysis LLC, Dome Dialysis LLC, Doves Dialysis LLC, Downriver Centers Inc., EURODIAL - Centro de Nefrologia e Dialise de Leiria S.A., East End Dialysis Center Inc., East Ft. Lauderdale LLC, Ebrea Dialysis LLC, Edisto Dialysis LLC, Eldrist Dialysis LLC, Elgin Dialysis LLC, Elk Grove Dialysis Center LLC, Empire State DC Inc., Etowah Dialysis LLC, Ettleton Dialysis LLC, Eufaula Dialysis LLC, Falcon LLC, Family Health Care of Central Florida, Fanthorp Dialysis LLC, Federal Way Assurance Inc., Fields Dialysis LLC, Five Star Dialysis LLC, Fjords Dialysis LLC, Flagler Dialysis LLC, Flamingo Park Kidney Center Inc., Forester Dialysis LLC, Freehold Artificial Kidney Center L.L.C., Fremont Dialysis LLC, Frontier Dialysis LLC, Fullerton Dialysis Center LLC, GDC International LLC, Gambro Healthcare, Ganois Dialysis LLC, Garner Dialysis LLC, Garrett Dialysis LLC, Gaviota Dialysis LLC, Gebhard Dialysis LLC, Genesis KC Development LLC, GiveLife Dialysis LLC, Glassland Dialysis LLC, Glosser Dialysis LLC, Goliad Dialysis LLC, Grand Home Dialysis LLC, Greater Las Vegas Dialysis LLC, Greater Los Angeles Dialysis Centers LLC, Green Country Dialysis LLC, Green Desert Dialysis LLC, Griffin Dialysis LLC, Groten Dialysis LLC, Harmony Dialysis LLC, Hart Dialysis LLC, Hawn Dialysis LLC, Healthcare Partners, Helmer Dialysis LLC, Hennepin Dialysis LLC, Hewett Dialysis LLC, Hilgards Dialysis LLC, Hochatown Dialysis LLC, Home Kidney Care LLC, Honeyman Dialysis LLC, Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership, Hummer Dialysis LLC, Hunter Dialysis LLC, Huntington Artificial Kidney Center Ltd., Hyde Dialysis LLC, IDC -International Dialysis Centers Lda, ISD Bartlett LLC, ISD Corpus Christi LLC, ISD I Holding Company Inc., ISD II Holding Company Inc., ISD Las Vegas LLC, ISD Lees Summit LLC, ISD Renal Inc., ISD Schaumburg LLC, ISD Spring Valley LLC, ISD Summit Renal Care LLC, Iroquois Dialysis LLC, Jacinto Dialysis LLC, Jenness Dialysis LLC, Kamiah Dialysis LLC, Kanika Dialysis LLC, Kavett Dialysis LLC, Kenai Dialysis LLC, Kershaw Dialysis LLC, Kidney Home Center LLC, Kimball Dialysis LLC, Kingston Dialysis LLC, Kinnick Dialysis LLC, Kinter Dialysis LLC, Kiowa Dialysis LLC, Knickerbocker Dialysis Inc., Lakeshore Dialysis LLC, Landing Dialysis LLC, Landor Dialysis LLC, Lassen Dialysis LLC, Leasburg Dialysis LLC, Leawood Dialysis LLC, Lees Dialysis LLC, Legare Development LLC, Liberty RC Inc., Lifeline Pensacola LLC, Lifeline Vascular Center-Albany LLC, Lincoln Park Dialysis Services Inc., Livingston Dialysis LLC, Llano Dialysis LLC, Lofield Dialysis LLC, Logoley Dialysis LLC, Lone Dialysis LLC, Long Beach Dialysis Center LLC, Lord Baltimore Dialysis LLC, Lory Dialysis LLC, Lourdes Dialysis LLC, Lyndale Dialysis LLC, MVZ DaVita Alzey GmbH, MVZ DaVita Aurich GmbH, MVZ DaVita Bad Aibling GmbH, MVZ DaVita Bad Duben GmbH, MVZ DaVita Cardio Centrum Dusseldorf GmbH, MVZ DaVita Dillenburg GmbH, MVZ DaVita Dinkelsbuhl GmbH, MVZ DaVita Dormagen GmbH, MVZ DaVita Duisburg GmbH, MVZ DaVita Elsterland GmbH, MVZ DaVita Emden GmbH, MVZ DaVita Falkensee GmbH, MVZ DaVita Geilenkirchen GmbH, MVZ DaVita Gera GmbH, MVZ DaVita Iserlohn GmbH, MVZ DaVita Monchengladbach GmbH, MVZ DaVita Neuss GmbH, MVZ DaVita Niederrhein GmbH, MVZ DaVita Nierenzentrum Aachen Alsdorf GmbH, MVZ DaVita Nierenzentrum Berlin-Britz GmbH, MVZ DaVita Nierenzentrum Hamm-Ahlen GmbH, MVZ DaVita Prenzlau-Pasewalk GmbH, MVZ DaVita Rhein-Ahr GmbH, MVZ DaVita Rhein-Ruhr GmbH, MVZ DaVita Schwalm-Eder GmbH, MVZ DaVita Viersen GmbH, Madigan Dialysis LLC, Magney Dialysis LLC, Magoffin Dialysis LLC, Makonee Dialysis LLC, Marlton Dialysis Center LLC, Marseille Dialysis LLC, Mason-Dixon Dialysis Facilities Inc., Mazonia Dialysis LLC, Mellen Dialysis LLC, Melnea Dialysis LLC, Memorial Dialysis Center L.P., Meridian Dialysis LLC, Mermet Dialysis LLC, Milltown Dialysis LLC, Minam Dialysis LLC, Minneopa Dialysis LLC, Mountain West Dialysis Services LLC, Mulgee Dialysis LLC, Nansen Dialysis LLC, Natomas Dialysis LLC, Nauvue Dialysis LLC, Navarro Dialysis LLC, Nephrology Medical Associates of Georgia LLC, Nephrology Practice Solutions LLC, New Bay Dialysis LLC, Nicona Dialysis LLC, Norbert Dialysis LLC, Norte Dialysis LLC, North Austin Dialysis LLC, Northwest Physicians Network, Oasis Dialysis LLC, Ohio River Dialysis LLC, Okanogan Dialysis LLC, Olive Dialysis LLC, Ordust Dialysis LLC, Owyhee Dialysis LLC, Palo Dialysis LLC, Palomar Dialysis LLC, Panther Dialysis LLC, Parkside Dialysis LLC, Pattison Dialysis LLC, Patuk Dialysis LLC, Pearl Dialysis LLC, Pendster Dialysis LLC, Percha Dialysis LLC, Pershing Dialysis LLC, Pfeiffer Dialysis LLC, Philadelphia-Camden Integrated Kidney Care LLC, Physicians Choice Dialysis LLC, Physicians Choice Dialysis Of Alabama LLC, Physicians Dialysis Acquisitions Inc., Physicians Dialysis Ventures LLC, Physicians Dialysis of Lancaster LLC, Physicians Management LLC, Pible Dialysis LLC, Pinson Dialysis LLC, Pittsburgh Dialysis Partners LLC, Piute Dialysis LLC, Plaine Dialysis LLC, Platte Dialysis LLC, Pluribus Dialise - Benfica S.A., Pluribus Dialise - Cascais S.A., Pluribus Dialise S.A., Prairie Dialysis LLC, Prineville Dialysis LLC, Purity Dialysis, RMS Lifeline Inc., RNA - DaVita Dialysis LLC, RV Academy LLC, Ramsey Dialysis LLC, Rayburn Dialysis LLC, Red Willow Dialysis LLC, Redcliff Dialysis LLC, Refuge Dialysis LLC, Renal Center of Beaumont LLC, Renal Center of Fort Dodge LLC, Renal Center of Lewisville LLC, Renal Center of Morristown LLC, Renal Center of Newton LLC, Renal Center of Port Arthur LLC, Renal Center of Tyler L.P.L.L.L.P., Renal Center of West Beaumont LLC, Renal Center of the Hills LLC, Renal Life Link Inc., Renal Treatment Centers - California Inc., Renal Treatment Centers - Illinois Inc., Renal Treatment Centers - Mid-Atlantic Inc., Renal Treatment Centers - Northeast Inc., Renal Treatment Centers - Southeast LP, Renal Treatment Centers - West Inc., Renal Treatment Centers Inc., Renal Ventures Management LLC, RenalServ LLC, Riddle Dialysis LLC, River Valley Dialysis LLC, Rocky Mountain Dialysis Services LLC, Rollins Dialysis LLC, Roose Dialysis LLC, Rophets Dialysis LLC, Roushe Dialysis LLC, Routt Dialysis LLC, Royale Dialysis LLC, Rusk Dialysis LLC, Rutland Dialysis LLC, SAKDC-DaVita Dialysis Partners L.P., Saddleback Dialysis LLC, Sahara Dialysis LLC, San Marcos Dialysis LLC, Santiam Dialysis LLC, Sapelo Dialysis LLC, Saunders Dialysis LLC, Seabay Dialysis LLC, Secour Dialysis LLC, Sensiba Dialysis LLC, Shadow Dialysis LLC, Shayano Dialysis LLC, Shelling Dialysis LLC, Sherman Dialysis LLC, Shetek Dialysis LLC, Shining Star Dialysis Inc., Siena Dialysis Center LLC, Simeon Dialysis LLC, Skagit Dialysis LLC, Soledad Dialysis Center LLC, Somerville Dialysis Center LLC, South Central Florida Dialysis Partners LLC, South Fork Dialysis LLC, Southern Hills Dialysis Center LLC, Southlake Dialysis LLC, Southwest Atlanta Dialysis Centers LLC, Sprague Dialysis LLC, Springpond Dialysis LLC, Star Dialysis LLC, Stevenson Dialysis LLC, Stewart Dialysis LLC, Stines Dialysis LLC, Storrie Dialysis LLC, Sugarloaf Dialysis LLC, Sun City Dialysis Center L.L.C., Sunapee Dialysis LLC, Sunset Dialysis LLC, TRC - Indiana LLC, TRC El Paso Limited Partnership, TRC West Inc., TRC of New York Inc., TRC-Georgetown Regional Dialysis LLC, Talimena Dialysis LLC, Terre Dialysis LLC, The Woodlands Dialysis Center LP, Tortugas Dialysis LLC, Total Renal Care Inc., Total Renal Care Texas Limited Partnership, Total Renal Care of North Carolina LLC, Total Renal Laboratories Inc., Total Renal Research Inc., Toulouse Dialysis LLC, Transmountain Dialysis L.P., Tross Dialysis LLC, Tugman Dialysis LLC, Tunnel Dialysis LLC, Turlock Dialysis Center LLC, Tustin Dialysis Center LLC, Twain Dialysis LLC, Tyler Dialysis LLC, USC-DaVita Dialysis Center LLC, Unicoi Dialysis LLC, University Dialysis Center LLC, Upper Valley Dialysis L.P., Valley Springs Dialysis LLC, Victory Dialysis LLC, VillageHealth DM LLC, Villanueva Dialysis LLC, Vively Health LLC, Vogel Dialysis LLC, Volo Dialysis LLC, Waddell Dialysis LLC, Wakoni Dialysis LLC, Walker Dialysis LLC, Walton Dialysis LLC, Watkins Dialysis LLC, Weldon Dialysis LLC, West Elk Grove Dialysis LLC, West Sacramento Dialysis LLC, Weston Dialysis Center LLC, Whitney Dialysis LLC, Willowbrook Dialysis Center L.P., Winds Dialysis LLC, Wood Dialysis LLC, Woodford Dialysis LLC, Wyandotte Central Dialysis LLC, Yards Dialysis LLC, Ybor City Dialysis LLC, Yucaipa Dialysis LLC, and Zephyrhills Dialysis Center LLC.
Read More
When was DaVita founded?

DaVita was founded in 1999.

How can I contact DaVita?

DaVita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The official website for the company is www.davita.com. The company can be reached via phone at (720) 631-2100, via email at ir@davita.com, or via fax at 302-636-5454.

This page (NYSE:DVA) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.